microRNA 4676 (MIR4676)

microRNA 4676 (MIR4676) is a human microRNA belonging to the class of short (about 20–24 nucleotide) non-coding RNAs that regulate gene expression at the post-transcriptional level[4][1]. Like other microRNAs, MIR4676 is processed from a primary RNA transcript through a series of nucleolytic cleavages to yield a mature functional form[5]. These molecules act primarily by binding to complementary sequences in the 3' untranslated region of target messenger RNAs, leading to mRNA degradation or translational inhibition[1]. There are no current data directly implicating microRNA 4676 in specific biological processes or diseases, and it has not been established as a clinically actionable target or biomarker. Its precise gene targets, mechanisms of action, and potential medical relevance remain to be defined. *Note: Most information about miRNAs as a molecular class can be extrapolated to MIR4676, but no MIR4676-specific literature describing unique functions, disease associations, or pharmacologically relevant properties was found as of 2024.*

Other names

hsa-mir-4676MIR4676hsa-mir-4676-5phsa-mir-4676-3p

Not determined for this microRNA specifically. In general, miRNAs inhibit translation or promote degradation of messenger RNA via partial sequence complementarity[1].